RXSIGHT, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.21 USD | +2.42% |
|
-3.18% | +49.33% |
| 05-13 | RxSight Raises $115 Million From Public Offering of Shares | MT |
| 05-07 | Wells Fargo Adjusts RxSight Price Target to $68 From $61, Maintains Overweight Rating | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 307.7 | 351.2 | 1,446 | 2,347 | - | - |
| Enterprise Value (EV) 1 | 322.3 | 378.8 | 1,436 | 2,246 | 2,240 | 2,218 |
| P/E ratio | -3.15 x | -5.26 x | -28.6 x | -73.7 x | -121 x | -245 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 13.6 x | 7.17 x | 16.2 x | 17.4 x | 13 x | 10.6 x |
| EV / Revenue | 14.3 x | 7.73 x | 16.1 x | 16.6 x | 12.4 x | 10 x |
| EV / EBITDA | -6.6 x | -6.37 x | -31.2 x | -77.3 x | -150 x | 472 x |
| EV / FCF | -6.91 x | -6.19 x | -30.9 x | -374 x | 747 x | 96.4 x |
| FCF Yield | -14.5% | -16.2% | -3.23% | -0.27% | 0.13% | 1.04% |
| Price to Book | 2.23 x | 3.9 x | 8.66 x | 13.9 x | 13.4 x | 11.8 x |
| Nbr of stocks (in thousands) | 27,354 | 27,722 | 35,862 | 38,982 | - | - |
| Reference price 2 | 11.25 | 12.67 | 40.32 | 60.21 | 60.21 | 60.21 |
| Announcement Date | 22-03-08 | 23-03-06 | 24-02-28 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net sales 1 | 22.59 | 49 | 89.08 | 135.2 | 180.9 | 221.8 |
| EBITDA 1 | -48.81 | -59.43 | -46.01 | -29.08 | -14.94 | 4.7 |
| EBIT 1 | -52.79 | -63.32 | -50.08 | -35.39 | -23.07 | -12.81 |
| Operating Margin | -233.64% | -129.21% | -56.23% | -26.18% | -12.76% | -5.77% |
| Earnings before Tax (EBT) 1 | -48.68 | -66.75 | -48.59 | -30.35 | -18.8 | -9.229 |
| Net income 1 | -48.69 | -66.76 | -48.61 | -30.38 | -18.87 | -9.649 |
| Net margin | -215.5% | -136.22% | -54.57% | -22.48% | -10.43% | -4.35% |
| EPS 2 | -3.570 | -2.410 | -1.410 | -0.8166 | -0.4963 | -0.2459 |
| Free Cash Flow 1 | -46.65 | -61.24 | -46.41 | -6 | 3 | 23 |
| FCF margin | -206.47% | -124.97% | -52.1% | -4.44% | 1.66% | 10.37% |
| FCF Conversion (EBITDA) | - | - | - | - | - | 489.36% |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - |
| Announcement Date | 22-03-08 | 23-03-06 | 24-02-28 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 8.427 | 8.942 | 11.36 | 12.62 | 16.09 | 17.49 | 20.81 | 22.2 | 28.58 | 29.51 | 32.38 | 33.2 | 40.14 | 40.11 | 42.6 |
| EBITDA 1 | -13.64 | -15.56 | -14.78 | -15.02 | -14.07 | -8.847 | -12.64 | -11.43 | -9.8 | -4.859 | -8.186 | -7.905 | -4.846 | -4.455 | -2.6 |
| EBIT 1 | -14.67 | -16.58 | -15.79 | -15.96 | -14.99 | -13.1 | -13.62 | -12.51 | -10.85 | -10.67 | -9.634 | -9.579 | -5.684 | -6.335 | -5.1 |
| Operating Margin | -174.04% | -185.39% | -139.01% | -126.5% | -93.18% | -74.89% | -65.47% | -56.36% | -37.97% | -36.15% | -29.75% | -28.85% | -14.16% | -15.79% | -11.97% |
| Earnings before Tax (EBT) 1 | -15.73 | -17.59 | -16.73 | -16.82 | -15.6 | -13.21 | -13.78 | -12.4 | -9.194 | -9.091 | -8.45 | -8.517 | -4.383 | -5.65 | -4.05 |
| Net income 1 | -15.73 | -17.6 | -16.73 | -16.82 | -15.61 | -13.21 | -13.8 | -12.42 | -9.176 | -9.1 | -8.479 | -8.282 | -4.408 | -5.118 | -4.05 |
| Net margin | -186.71% | -196.78% | -147.29% | -133.32% | -97.03% | -75.54% | -66.33% | -55.93% | -32.11% | -30.83% | -26.18% | -24.95% | -10.98% | -12.76% | -9.51% |
| EPS 2 | -0.5800 | -0.6400 | -0.6100 | -0.6100 | -0.5600 | -0.4200 | -0.4000 | -0.3500 | -0.2600 | -0.2500 | -0.2261 | -0.2207 | -0.1149 | -0.1500 | -0.1067 |
| Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Announcement Date | 22-03-08 | 22-05-05 | 22-08-08 | 22-11-07 | 23-03-06 | 23-05-09 | 23-08-07 | 23-11-09 | 24-02-28 | 24-05-06 | - | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 14.6 | 27.6 | - | - | - | - |
| Net Cash position 1 | - | - | 10.4 | 101 | 107 | 129 |
| Leverage (Debt/EBITDA) | -0.2989 x | -0.4639 x | - | - | - | - |
| Free Cash Flow 1 | -46.6 | -61.2 | -46.4 | -6 | 3 | 23 |
| ROE (net income / shareholders' equity) | -144% | -58.5% | -38.8% | -13.9% | -6.52% | 2.25% |
| ROA (Net income/ Total Assets) | -29.9% | -38.9% | -29.2% | -15.6% | -13% | -10% |
| Assets 1 | 163 | 171.4 | 166.4 | 194.9 | 145.4 | 96.35 |
| Book Value Per Share 2 | 5.040 | 3.250 | 4.650 | 4.330 | 4.490 | 5.110 |
| Cash Flow per Share 2 | - | -2.130 | -1.210 | -0.6000 | 0.1500 | - |
| Capex 1 | 1.94 | 2.39 | 4.81 | 4 | 8.95 | 7.35 |
| Capex / Sales | 8.59% | 4.88% | 5.4% | 2.96% | 4.95% | 3.31% |
| Announcement Date | 22-03-08 | 23-03-06 | 24-02-28 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
D
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
60.21
USD
Average target price
72.75
USD
Spread / Average Target
+20.83%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +49.33% | 2.35B | |
| -5.51% | 181B | |
| +2.33% | 112B | |
| -3.62% | 67.92B | |
| +1.52% | 50.1B | |
| +8.06% | 44.27B | |
| +8.37% | 40.41B | |
| +23.35% | 31.95B | |
| +0.67% | 25.82B | |
| +17.07% | 25.29B |
- Stock Market
- Equities
- RXST Stock
- Financials RxSight, Inc.